title: Psychotropic medication management for youth in state care: consent, oversight, and policy considerations.
abstract: The use of psychotropic medications in youth with emotional disturbances in state custody is increasing and presents unique challenges concerning consent and oversight. We examine various means that state child welfare agencies use to provide consent for and oversight of psychotropic medications for children in state custody and describe benefits of a consent process that provides for expert consultation to the child welfare agency and prescribing clinicians, case-specific and systemic oversight of psychotropic medication use, and education for stakeholders.
authors.affiliation: Clinical Services in Psychopharmacology Program, Institute for Juvenile Research, University of Illinois at Chicago, Department of Psychiatry, Chicago, Illinois, USA. mnaylor@psych.uic.edu
authors.forename: Michael W
authors.initials: MW
authors.lastname: Naylor
authors.forename: Christine V
authors.initials: CV
authors.lastname: Davidson
authors.forename: D Jean
authors.initials: DJ
authors.lastname: Ortega-Piron
authors.forename: Arin
authors.initials: A
authors.lastname: Bass
authors.forename: Alice
authors.initials: A
authors.lastname: Gutierrez
authors.forename: Angela
authors.initials: A
authors.lastname: Hall
mesh_terms: D000293:Adolescent; D000342:Affective Symptoms / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D019090:Case Management / Q000331:legislation & jurisprudence*; D002648:Child; D002653:Child Behavior Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D002655:Child Custody / Q000331:legislation & jurisprudence*; D002669:Child Welfare / Q000523:psychology*; D017277:Drug Approval / Q000331:legislation & jurisprudence; D005104:Expert Testimony / Q000331:legislation & jurisprudence; D006291:Health Policy / Q000331:legislation & jurisprudence; D006801:Humans; D007258:Informed Consent / Q000331:legislation & jurisprudence*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012017:Referral and Consultation / Q000331:legislation & jurisprudence; D013313:Stress Disorders, Post-Traumatic / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D020458:Third-Party Consent / Q000331:legislation & jurisprudence*; D014481:United States
chemical_list: D011619:Psychotropic Drugs